News

Article

Innovations move refractive surgery along path back to the surface

As the evolution in refractive surgery continues, surgeons can expect to see the journey continuing back to the surface - aided by new strategies to improve the outcomes of sub-Bowman's keratomileusis (SBK) and PRK, said John Marshall, PhD, in his keynote address at Refractive Surgery Day.

As the evolution in refractive surgery continues, surgeons can expect to see the journey continuingback to the surface-aided by new strategies to improve the outcomes of sub-Bowman'skeratomileusis (SBK) and PRK, said John Marshall, PhD, in his keynote address at Refractive Surgery SubspecialtyDay.

SBK, involving creation of a very superficial flap using a femtosecond laser, was introduced toprovide the benefits of both LASIK and PRK. Since creation of the very thin flap minimally reducesthe strength of the cornea, SBK is expected to provide the biomechanical stability of PRK, but likeLASIK, without the pain and haze that are sequelae of post-PRK wound healing, he said.

Looking to the future, Dr. Marshall suggested biomechanical stability after SBK can be furtherimproved by changing the edge angle of the flap.

"Making the edge angle more oblique makes the flap stronger," said Dr. Marshall, head of thedepartment of ophthalmology, Kings College, London.

Recognizing that wound healing is a limiting variable for PRK, Dr. Marshall suggested the surfaceablation procedure will be improved by pharmacologic modulation of that process. Possible strategiesinclude use of the simple sugar, mannose 6-phosphate, and aptamer technology.

"Studies from our group show that mannose 6-phosphate, which blocks receptor sites on keratocytes, iseffective in preventing haze in animal models," Dr. Marshall said. "In addition, we have found thataptamers selectively differentiating between activated and latent keratocytes can be used fortargeted wound healing control."

Dr. Marshall is featured in Ophthalmology Times' AAO Podcast Series. To listen to an interview with Dr. Marshall, click here.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) NeuroOp Guru: Using OCT to forecast outcomes in ethambutol optic neuropathy
(Image credit: Ophthalmology Times) Inside NYEE’s new refractive solutions center with Kira Manusis, MD
(Image credit: Ophthalmology Times) Dilsher Dhoot, MD, on the evolution of geographic atrophy therapy: where are we now?
(Image credit: Ophthalmology Times Europe) Anat Loewenstein, MD, shares insights on the real-world results of remote retinal imaging
(Image credit: Ophthalmology Times) Two-wavelength autofluorescence for macular xanthophyll carotenoids with Christine Curcio, PhD
(Image credit: Ophthalmology Times) FLIO and the brain: Making the invisible visible with Robert Sergott, MD
(Image credit: Ophthalmology Times) Structure-function correlates using high-res OCT images with Karl Csaky, MD, PhD
(Image credit: Ophthalmology Times) SriniVas Sadda, MD, on high-res OCT of atrophic and precursor lesions in AMD
(Image credit: Ophthalmology Times) Christine Curcio, PhD, shares histology update supporting review software and revised nomenclature for <3 μm OCT
© 2025 MJH Life Sciences

All rights reserved.